• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    Amicus Therapeutics, Inc. (FOLD)

    -NasdaqGM
    7.47 Down 0.28(3.61%) 4:00PM EDT
    |After Hours : 7.47 0.00 (0.00%) 4:23PM EDT - Nasdaq Real Time Price
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue -   1,224   363  
    Cost of Revenue -   -   -  
    Gross Profit -   1,224   363  
    Operating Expenses
    Research Development76,943  47,624  41,944  
    Selling General and Administrative51,646  20,817  18,893  
    Non Recurring15  (63)1,988  
    Others1,833  1,547  1,719  
    Total Operating Expenses130,437  69,925  64,544  
    Operating Income or Loss (130,437) (68,701) (64,181)
    Income from Continuing Operations
    Total Other Income/Expenses Net(103)146  1,082  
    Earnings Before Interest And Taxes(130,540)(68,555)(63,099)
    Interest Expense1,578  1,484  46  
    Income Before Tax(132,118)(70,039)(63,145)
    Income Tax Expense -  (1,113)(3,512)
    Minority Interest -   -   -  
    Net Income From Continuing Ops(132,118)(68,926)(59,633)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (132,118) (68,926) (59,633)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (132,118) (68,926) (59,633)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.